Takeda Pharmaceutical Company
-
Ticker
TAK
-
Industry
Drug Manufacturers - Other More
-
Sector
Healthcare More
- 10,000+ Employees
- Based in Tokyo, Japan
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology
…More (GI). They also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. They are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging their enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Their employees are committed to improving quality of life for patients and to working with their partners in health care in approximately 80 countries.
REPORT RATINGS
4.8 / 5.0 (94)
Takeda Pharmaceutical Company reports have an aggregate usefulness score of 4.8 based on 94 reviews.
Takeda Pharmaceutical Company
Most Recent Responsibility Report
MOST RECENT
2023 Responsibility Report
Report Locked. Takeda Pharmaceutical Company has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Takeda Pharmaceutical Company Sustainability Report, Takeda Pharmaceutical Company Corporate Social Responsibility Report, Takeda Pharmaceutical Company CSR Report, Takeda Pharmaceutical Company Corporate Responsibility, Takeda Pharmaceutical Company CR Report, Takeda Pharmaceutical Company Citizenship Report, Takeda Pharmaceutical Company ESG Report, and Takeda Pharmaceutical Company Environmental Report online.